News Focus
News Focus
icon url

scotty3371

05/22/24 6:49 AM

#693141 RE: dennisdave #693140

Sold or given away or paid for by another party to continue testing poly iclc and keytruda efficacy?
icon url

biosectinvestor

05/22/24 9:09 AM

#693165 RE: dennisdave #693140

I did not suggest any sales number. I have no idea. But the way the UK Psecials program is set-up by the regulator, for payment, after some due diligence I believe that it is not intended for us as investors or anyone else to know much about what is happening before they are approved.

Moreover, as you know, it is all OUT-OF-POCKET, the UK is a relatively small jurisdiction in terms of potential cases in any one year and the treatment is not approved yet, so not everyone’s personal doctor is going to know about it. So that demand, whatever it is, is not likely a determinant of anything at this stage.
icon url

dstock07734

05/22/24 9:58 AM

#693193 RE: dennisdave #693140